Wednesday, 18 Oct 2017

You are here

H1N1 Vaccination Triggers TLR Activation and Autoantibody Production in DMARD-naïve pSS

Increased morbidity and mortality from infectious causes in patients with autoimmune disorders has led to the overall consensus that vaccination of such patients is important and should be widely promoted in clinical practice. However, the autoimmune-biased immune system of the patient with rheumatic disease and use of immunosuppressive drugs tend to affect response to vaccination.

Published studies have shown reduced immunization responses with decreased protective antibody titers in such patients. As H1N1-related mortality amongst a younger population increased, it has become a common practice to provide protective immunization to all.

This Swedish study was designed to assess immune response to the vaccine of DMARD naïve primary Sjogren’s (pSS) patients. Primary SS patient with +SSA and SSB antibodies and matched healthy controls were vaccinated twice with adjuvanted inactivated H1N1 vaccine. Blood samples were collected and clinical parameters assess prior to, at week 1 and week 3 after each vaccination.

Researchers observed markedly higher levels of H1N1 influenza-specific IgG antibodies in patients, mainly of the IgG1 subclass, compared with controls. Furthermore, H1N1 antibodies developed by the patients had higher avidity than those of controls. Similar response was observed with influenza A and B strains.

Further investigation of antibodies to non-influenza pathogen Epstein-Barr virus (EBV) showed that antibody titers to EBV increased in patients following vaccination, but not incontrols. In terms of clinical response, increased frequency of fever, fatigue, myalgia and arthralgia were observed during the vaccination period.

H1N1 vaccination in pSS induced higher specific antibody responses in untreated autoimmune patients with pSS, and drove polyclonal B cell activation, including that of autoreactive cells, leading to an increase in autoantibody titers. High basal serum levels of the pro-inflammatory cytokines IFN-α, BAFF and TNF-α were observed in untreated patients with pSS during vaccination period. Researchers speculated that such response is possibly due to endosomal TLR stimulation (TLR7 and TLR9 in particular).

That would also explain the fact that such stimulatory effect was abolished in patient treated with hydroxychloroquine (HCQ). It is known that HCQ acts by inhibiting endosomal TLR signaling and subsequent B cell class switch and cytokine production.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

So does the study with treatment naive patients and influenza vaccine mean we should or should not vaccinate this group of patients?

More Like This

BSR Guidelines on Lupus Management

In the UK, NICE has accredited the British Society of Rheumatology (BSR) to develop a guidance document on the management of systemic lupus erythematosus in adults.  The last published guidelines for lupus were published in 2008 by EULAR and in 2012 by the ACR.

IBD Associated with Increased risk of Autoimmune and Inflammatory Diseases

A registry based study has shown higher rates of immune mediated diseases (IMD) in patients with inflammatory bowel disease (IBD).

Researchers examined 47325 IBD patients from the Danish National Patient Registry and compared them to controls from a civilian registry and used ICD 10 codes to identify the diagnoses observed.

Primary Sjögren's Syndrome Guideline from the British Society for Rheumatology

The British Society of Rheumatology (BSR) has been accredited by NICE to develop a guidance document for the management of primary Sjögren's Syndrome intended for rheumatologists, general physicians, general practitioners, specialist nurses and other specialists (e.g. ophthalmologists, dental practitioners and ENT specialists),

Isolated SS-B Not Associated with Connective Tissue Disease

A one-year prospective study of 624 patients undergoing autoantibody testing for anti-SS-A and/or anti-SS-B autoantibodies finds that isolated anti-SS-B autoantibodies was not associated with features or the diagnosis of any specific connective tissue diseases (CTD).

Half of Takayasu's Arteritis Relapse

A French retrospective study of 318 Takayasu's arteritis (TA) patients shows that 50% of patients will relapse and experience a vascular complication ≤10 years from diagnosis.